You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malignant External Otitis

Comparison of Monotherapy vs Combination Therapy

Burt R. Meyers, MD; Meryl H. Mendelson, MD; Simon C. Parisier, MD; Shalom Z. Hirschman, MD

Arch Otolaryngol Head Neck Surg. 1987;113(9):974-978.


Abstract

• Twenty patients with adult-onset diabetes mellitus and malignant external otitis (MEO) were treated at the Mount Sinai Medical Center, New York, over a seven-year period (August 1976 to October 1983). A retrospective analysis compared patients who received an antipseudomonal cephalosporin as monotherapy (group A) with those who received conventional antipseudomonal therapy (group B). Pseudomonas aeruginosa was isolated in all patients. Differences (group B > group A) included insulin dependence, underlying vascular disease, total number of cranial nerve palsies or paresis, and surgical procedures. The overall clinical outcome was similar in both groups; 64% of patients in group A (7/11) and 70% in group B (7/10) were cured at a follow-up period of five to 57 months. A more favorable outcome was found in patients with less extensive infection in both groups. Monotherapy compared favorably with conventional antipseudomonal therapy for the treatment of patients with MEO and moderate infection.

(Arch Otolaryngol Head Neck Surg 1987;113:974-978)



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine (Drs Meyers, Mendelson, and Hirschman), and the Department of Otolaryngology (Dr Parisier), Mount Sinai School of Medicine, New York. Dr Parisier is now with the Manhattan Eye, Ear, and Throat Hospital, New York.


Footnotes

Accepted for publication April 17, 1987.

Reprint requests to Division of Infectious Diseases, Box 1090, Mount Sinai Medical Center, One Gustave L. Levy Pl, New York, NY 10029 (Dr Meyers).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adjuvant Hyperbaric Oxygen in Malignant External Otitis
Davis et al.
Arch Otolaryngol Head Neck Surg 1992;118:89-93.
ABSTRACT  

Hyperbaric Oxygenation for Necrotizing (Malignant) Otitis Externa
Shupak et al.
Arch Otolaryngol Head Neck Surg 1989;115:1470-1475.
ABSTRACT  

Efficacy of Oral Ciprofloxacin Plus Rifampin for Treatment of Malignant External Otitis
Rubin et al.
Arch Otolaryngol Head Neck Surg 1989;115:1063-1069.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.